Basic Care Daytime Severe Cold Nighttime Cold And Flu

Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride


L. Perrigo Company
Human Otc Drug
NDC 0113-7951
Basic Care Daytime Severe Cold Nighttime Cold And Flu also known as Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride is a human otc drug labeled by 'L. Perrigo Company'. National Drug Code (NDC) number for Basic Care Daytime Severe Cold Nighttime Cold And Flu is 0113-7951. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Basic Care Daytime Severe Cold Nighttime Cold And Flu drug includes . The currest status of Basic Care Daytime Severe Cold Nighttime Cold And Flu drug is Active.

Drug Information:

Drug NDC: 0113-7951
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Basic Care Daytime Severe Cold Nighttime Cold And Flu
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, Diphenhydramine Hydrochloride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: L. Perrigo Company
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Kit
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 24 Jan, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 07 May, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part341
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:L. Perrigo Company
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:1046751
1110988
1424551
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0113-7951-811 KIT in 1 KIT (0113-7951-81) * 10 BLISTER PACK in 1 CARTON / 2 TABLET, FILM COATED in 1 BLISTER PACK * 5 BLISTER PACK in 1 CARTON / 2 TABLET, FILM COATED in 1 BLISTER PACK24 Jan, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purposes - day time severe cold pain reliever/fever reducer cough suppressant expectorant nasal decongestant

Purposes - night time cold & flu pain reliever/fever reducer antihistamine nasal decongestant

Product Elements:

Basic care daytime severe cold nighttime cold and flu acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, diphenhydramine hydrochloride basic care day time severe cold acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride acetaminophen acetaminophen dextromethorphan hydrobromide dextromethorphan guaifenesin guaifenesin phenylephrine hydrochloride phenylephrine croscarmellose sodium crospovidone (15 mpa.s at 5%) fd&c blue no. 2 fd&c red no. 40 maltodextrin microcrystalline cellulose polyethylene glycol, unspecified polyvinyl alcohol, unspecified povidone, unspecified silicon dioxide stearic acid talc titanium dioxide l922 basic care night time cold and flu acetaminophen, diphenhydramine hydrochloride, phenylephrine hydrochloride acetaminophen acetaminophen diphenhydramine hydrochloride diphenhydramine phenylephrine hydrochloride phenylephrine crospovidone (15 mpa.s at 5%) fd&c blue no. 1 magnesium stearate microcrystalline cellulose polyethylene glycol, unspecified polyvinyl alcohol, unspecified povidone, unspecified silicon dioxide stearic acid talc titanium dioxide

Indications and Usage:

Uses • temporarily relieves these common cold and flu symptoms: • nasal congestion • cough (day time severe cold only) • minor aches and pains • headache • sore throat • runny nose and sneezing (night time cold & flu only) • helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive (day time severe cold only) • temporarily reduces fever

Warnings:

Warnings liver warning: these products contain acetaminophen. severe liver damage may occur if you take • more than 4,000 mg of acetaminophen in 24 hours • with other drugs containing acetaminophen • 3 or more alcoholic drinks every day while using these products allergy alert: acetaminophen may cause severe skin reactions. symptoms may include: • skin reddening • blisters • rash if a skin reaction occurs, stop use and seek medical help right away. sore throat warning: if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

Do Not Use:

Warnings liver warning: these products contain acetaminophen. severe liver damage may occur if you take • more than 4,000 mg of acetaminophen in 24 hours • with other drugs containing acetaminophen • 3 or more alcoholic drinks every day while using these products allergy alert: acetaminophen may cause severe skin reactions. symptoms may include: • skin reddening • blisters • rash if a skin reaction occurs, stop use and seek medical help right away. sore throat warning: if sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.

When Using:

When using these products • do not use more than directed • excitability may occur, especially in children (night time cold & flu only) • marked drowsiness may occur (night time cold & flu only) • alcohol, sedatives, and tranquilizers may increase drowsiness (night time cold & flu only) • avoid alcoholic drinks (night time cold & flu only) • be careful when driving a motor vehicle or operating machinery (night time cold & flu only)

Dosage and Administration:

Directions • do not take more than directed (see overdose warning) • do not take more than 10 caplets in any 24-hour period • adults and children 12 years of age and older: take 2 caplets every 4 hours • children under 12 years of age: do not use

Stop Use:

Stop use and ask a doctor if • nervousness, dizziness, or sleeplessness occur • pain, nasal congestion or cough gets worse or lasts more than 7 days • fever gets worse or lasts more than 3 days • redness or swelling is present • new symptoms occur • cough comes back or occurs with rash or headache that lasts. these could be signs of a serious condition. (day time severe cold only)

Package Label Principal Display Panel:

Package/label principal display panel compare to mucinex ® fast-max ® day time & night time active ingredients maximum strength for ages 12+ daytime severe cold acetaminophen dextromethorphan hbr guaifenesin phenylephrine hcl pain reliever fever reducer cough suppressant expectorant nasal decongestant relieves aches, fever & sore throat controls cough relieves nasal & chest congestion thins & loosens mucus actual size 20 caplets for ages 12+ night time cold & flu acetaminophen diphenhydramine hcl phenylephrine hcl pain reliever fever reducer antihistamine nasal decongestant relieves aches, fever & sore throat relieves nasal congestion relieves runny nose & sneezing actual size 10 caplets 951an-daytime-nitetime-image1.jpg 951an-daytime-nitetime-image2.jpg 951an-daytime-nitetime-image3.jpg

Further Questions:

Questions or comments? 1-800-719-9260


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.